Delivery Order SPE2DB24D1104-SPE2DB24FXTW1

Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government agency the Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,015.56 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a firm fixed-price agreement for the delivery of pharmaceutical products and medical supplies. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a $7,022.60 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide pharmaceutical products and medical supplies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to the Department of...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,590.30 delivery order contract to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to federal agencies. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA, which serves as the primary vehicle for the company to deliver a comprehensive range of medical commodities, including specialty, brand name, generic,...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $25,129.86. The contract is for the supply of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
The U.S. Defense Logistics Agency (DLA) awarded a $11,030.84 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical and medical supply distributor. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceuticals and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $2,740.44 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of pharmaceutical and medical products. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of medications, medical devices, and supplies to DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,233.43 firm fixed-price delivery order is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,772.21 firm fixed-price delivery order is for the supply of ACTEMRA 200 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $11,720.08 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the provision of pharmaceutical products and medical supplies, including specialty, brand-name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This order is part of a larger Indefinite Delivery Contract (IDC)...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $8,860.32 Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This Delivery Order is part of a larger Indefinite Delivery Contract...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FXTW1
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,315.44 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the agency to efficiently procure essential medical commodities for military treatment programs and facilities worldwide. The current delivery order is for the supply of ACTEMRA 162 MG/0.9 ML syringes. This contract does not have a set-aside designation.

Generated 7/18/24, 10:01 AM